Skip to content

Sarissa Capital Management LP

Follow

13F filer, CIK 1577524, GREENWICH, CT

Sarissa Capital Management LP reported $153,172,008 across 10 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.

Accepted , ingested 13F-HR 0001420506-26-002892

Period
2026-09-30
Reported value
$153M
Holdings
10
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AMRNreduced-386,305-$5.02M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001420506-26-002892, largest first. % of portfolio is the value over $153,172,008, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INVAINNOVIVA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,277,000 shares; 2025Q1: 2,816,022 shares; 2025Q2: 2,816,022 shares; 2025Q3: 2,816,022 shares; 2025Q4: 2,816,022 shares; 2026Q1: 2,130,950 shares; 2026Q2: 1,890,604 shares; 2026Q3: 1,890,604 shares 1,890,604$40.1M26.18%0Timeline
IRWDIRONWOOD PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 16,390,000 shares; 2025Q1: 16,390,000 shares; 2025Q2: 15,919,435 shares; 2025Q3: 15,919,435 shares; 2025Q4: 15,919,435 shares; 2026Q1: 9,188,635 shares; 2026Q2: 9,188,635 shares; 2026Q3: 9,188,635 shares 9,188,635$36.5M23.82%0Timeline
AMRNAMARIN CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,242,527 shares; 2025Q3: 1,242,527 shares; 2025Q4: 1,673,395 shares; 2026Q1: 1,673,395 shares; 2026Q2: 1,673,395 shares; 2026Q3: 1,287,090 shares 1,287,090$16.7M10.92%-386,305Timeline
LNTHLANTHEUS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 63,000 shares; 2025Q1: 100,000 shares; 2025Q2: 96,251 shares; 2025Q3: 181,450 shares; 2025Q4: 181,450 shares; 2026Q1: 166,919 shares; 2026Q2: 166,919 shares; 2026Q3: 166,919 shares 166,919$16.6M10.85%0Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 309,116 shares; 2025Q1: 309,116 shares; 2025Q2: 303,151 shares; 2025Q3: 303,151 shares; 2025Q4: 303,151 shares; 2026Q1: 116,533 shares; 2026Q2: 116,533 shares; 2026Q3: 116,533 shares 116,533$16.5M10.79%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 833,799 shares; 2025Q1: 600,000 shares; 2025Q2: 588,357 shares; 2025Q3: 588,357 shares; 2025Q4: 396,357 shares; 2026Q1: 228,623 shares; 2026Q2: 228,623 shares; 2026Q3: 228,623 shares 228,623$15.1M9.84%0Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 513,184 shares; 2026Q1: 563,184 shares; 2026Q2: 582,312 shares; 2026Q3: 582,312 shares 582,312$7.77M5.08%0Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,190 shares; 2025Q4: 4,190 shares; 2026Q1: 4,190 shares; 2026Q2: 4,190 shares; 2026Q3: 4,190 shares 4,190$3.18M2.07%0Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 25,399 shares; 2025Q4: 25,399 shares; 2026Q1: 25,399 shares; 2026Q2: 25,399 shares; 2026Q3: 25,399 shares 25,399$485K0.32%0Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 950 shares; 2026Q3: 950 shares 950$215K0.14%0Timeline

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-002892 base2026-11-16